Quantcast

Latest Pharmacology Stories

2014-07-23 23:04:12

One of California’s leading Medicaid plans adopts SafeUseNow to quickly identify and help stop prescription drug abuse ENCINITAS, Calif. (PRWEB) July 23, 2014 SafeUseNow℠, a prescription drug abuse risk identification and intervention program developed by Principled Strategies, today announced a service agreement with Partnership HealthPlan of California. Utilizing SafeUseNow’s patent-pending risk model, Partnership HealthPlan can quickly identify patients at risk of misusing and...

2014-07-23 23:02:10

On July 24th, at 6:00 pm - 8 pm PST, an expert panel is gathering in Modesto, California. Watch "AWAKEN AMERICA" a Live Streaming event online at http://www.420insight.com. Modesto, California (PRWEB) July 23, 2014 The following physicians and experts discuss their experiences with medical marijuana, how it saves lives, and why it should be legal nationwide. The guest lineup offers the top movers and shakers advocating medical marijuana. Included are: Dr. Thomas F. Minahan:...

2014-07-23 16:26:42

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Partial Seizure Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2243634/Partial-Seizure-Global-Clinical-Trials-Review-H2-2014.htmlPartial Seizure Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Partial Seizure Global Clinical Trials Review, H2, 2014" provides data on the Partial Seizure clinical trial scenario. This report provides...

2014-07-23 16:26:38

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Neonatal Seizures Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2243633/Neonatal-Seizures-Global-Clinical-Trials-Review-H2-2014.htmlNeonatal Seizures Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Neonatal Seizures Global Clinical Trials Review, H2, 2014" provides data on the Neonatal Seizures clinical trial scenario. This report...

2014-07-23 16:26:32

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Intracerebral Hemorrhage Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2243630/Intracerebral-Hemorrhage-Global-Clinical-Trials-Review-H2-2014.htmlIntracerebral Hemorrhage Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Intracerebral Hemorrhage Global Clinical Trials Review, H2, 2014" provides data on the Intracerebral Hemorrhage...

2014-07-23 12:32:49

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Hypoxic-Ischemic Encephalopathy Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2243628/Hypoxic-Ischemic-Encephalopathy-Global-Clinical-Trials-Review-H2-2014.htmlHypoxic-Ischemic Encephalopathy Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Hypoxic-Ischemic Encephalopathy Global Clinical Trials Review, H2, 2014" provides data on...

2014-07-23 12:32:39

HOUSTON, July 23, 2014 /PRNewswire-USNewswire/ -- V. Craig Jordan, Ph.D., one of the world's preeminent breast cancer experts will join The University of Texas MD Anderson Cancer Center this fall. Jordan is considered the "Father of Tamoxifen," the groundbreaking therapeutic drug that has saved countless lives. http://photos.prnewswire.com/prnvar/20140723/129913 As a professor in Breast Medical Oncology and Molecular and Cellular Oncology, Jordan will focus on the new biology of...

2014-07-23 12:32:31

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Generalized Seizures Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2243626/Generalized-Seizures-Global-Clinical-Trials-Review-H2-2014.htmlGeneralized Seizures Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Generalized Seizures Global Clinical Trials Review, H2, 2014" provides data on the Generalized Seizures clinical trial...

2014-07-23 12:31:16

Study quantifies lost savings from REMS and related restricted access tactics WASHINGTON, July 23, 2014 /PRNewswire-iReach/ -- Use of Risk Evaluation and Mitigation Strategies (REMS) and other restricted access programs to delay generic market entry results in $5.4 billion in lost savings annually, according to a new survey and analysis by economic consulting firm Matrix Global Advisors (MGA). Logo - http://photos.prnewswire.com/prnh/20140723/129680 Required by the Food and Drug...

2014-07-23 08:32:15

LAS VEGAS, July 23, 2014 /PRNewswire/ -- DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider that is expanding into the cannabis testing and education markets, announced the filing of its periodic report on Form 10-Q for the quarter ended June 30, 2014, which disclosed the consummation of financings in the aggregate amount of $8.2 million from accredited investors during its third fiscal quarter. http://photos.prnewswire.com/prnvar/20140605/94753 Of the...


Latest Pharmacology Reference Libraries

Pharmacophobia
2013-12-24 12:55:45

Pharmacophobia or medication phobia, comes from Greek pharmakon, meaning “drug, medicine” and phobos, meaning “fear”, is the fear of the use of pharmacological treatments. In severe, excessive, and irrational cases, it might be a type of specific phobia. While lack of awareness by patient of adverse drug reactions can have a serious consequence, having a phobia of medications can also have serious detrimental effects on the patient’s health. Medication phobia can also lead to...

Generalized Anxiety Disorder
2013-07-25 15:07:54

Generalized Anxiety Disorder (GAD) is an anxiety disorder with worry about normal, everyday situations such as finance, health and wellbeing in relationships (personal and work related) all lasting longer than six months. Symptoms The symptoms of GAD can include but are not limited to difficulty swallowing, rashes, shortness of breath, fidgeting, headaches, tension, nausea, etc. In order for GAD to be ruled as present, the symptoms and feelings must be experiences for at least six...

European Journal of Medical Chemistry
2012-05-12 22:03:06

The European Journal of Medical Chemistry is a peer-reviewed scientific journal for medical chemistry. It is published by Elsevier. It was established in 1966 under the title Chimica Therapeutica. That name was maintained until 1973. Even after changing to its current name in 1974, the journal was still subtitled Chimica Therapeutica until 1981; from 1982 to 1986 it was subtitled Chimie Therapeutique, indicating its French origin. The Journal publishes studies on all aspects of medicinal...

0_3ff7149ca288229c28bcd855846ea8c7
2009-04-28 16:00:11

Bursera graveolens or Palo Santo is a tree indigenous to South America in Argetina, Paraguay, Boliva and coastal areas of Ecuador. Palo Santo means "holy wood" in English and belongs in the same family as frankincense and myrrh. Although it has been used in homeopathic medicine for years, most recently it is the extraction of essential oils that has put this plant in the spotlight. Limonene, a-Terpineol, Menthofuran and Carvone are a few of the oils derived from this plant. Native...

31_c737ff73aa3c47be364b2a8cce214e0c
2005-07-12 18:32:21

Datura wrightii (a poisonous weed) is sometimes used as a hallucinogen. It is commonly called Sacred Datura. Datura wrightii is classified as a deliriant, or an anticholinergic. In the US it is, however, called Western Jimson Weed.

More Articles (5 articles) »
Word of the Day
toccata
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.
Related